Company invites individual and institutional investors, as well as advisors, to log-on to view the presentation
COPENHAGEN, Denmark, March 26, 2018 /PRNewswire/ — Genmab A/S (CPH: GEN, OTC:GMXAY), focused on the creation and development of differentiated antibody therapeutics for the…
